癌・腫瘍プロファイリングの世界市場予測(~2021):用途別、手法別(ゲノミクス、 プロテオミクス、メタボロミクス、エピジェネティックス)、技術別(次世代シーケンシング、qPCR、in-situハイブリダイゼーション、マイクロアレイ)...市場調査レポートについてご紹介

【英文タイトル】Cancer/Tumor Profiling Market by Application (Diagnostic, Personalized Medicine, Research), Technique (Genomics, Proteomics, Metabolomics, Epigenetics),Technology (Next-generation Sequencing, qPCR, In-situ Hybridization, Microarray)- Forecast to 2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.3 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 18)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.2.1 Key Data From Secondary Sources
2.2.2 Key Data From Primary Sources
2.2.2.1 Key Industry Insights
2.2.3 Assumptions for the Study
2.3 Macroeconomic Factor Analysis
2.3.1 Introduction
2.3.2 Demand-Side Analysis
2.3.2.1 Healthcare Expenditure Pattern
2.3.3 Supply-Side Analysis
2.3.3.1 Number of New Product Launches

3 Executive Summary (Page No. – 27)

4 Premium Insights (Page No. – 31)
4.1 Tumor Profiling Market: Market Overview
4.2 Geographic Analysis: Tumor Profiling Market, By Technique (2016)
4.3 Global Tumor Profiling Market Size, By Technology, 2016 vs 2021
4.4 Global Tumor Profiling Market Size, By Application, 2016 vs 2021
4.5 Tumor Profiling Market: Geographic Growth Opportunities

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of New Cancer Cases
5.2.1.2 Increasing Utility of Biomarkers in Tumor Profiling
5.2.1.3 Availability of Funding for Cancer Research
5.2.2 Restraints
5.2.2.1 High Capital Investments and Low Benefit Ratio for Biomarkers
5.2.2.2 Lack of Skilled Professionals and Infrastructure
5.2.3 Opportunities
5.2.3.1 Point-Of-Care Diagnostic Tests
5.2.3.2 Increasing Demand for Personalized Medicine
5.2.4 Challenges
5.2.4.1 Unclear Regulatory and Reimbursement Scenario

6 Cancer Profiling Market, By Application (Page No. – 43)
6.1 Introduction
6.2 Personalized Medicine
6.3 Diagnostics
6.4 Biomarker Discovery
6.5 Prognostics
6.6 Research Applications

7 Cancer Profiling Market, By Technique (Page No. – 54)
7.1 Introduction
7.2 Genomics
7.3 Proteomics
7.4 Epigenetics
7.5 Metabolomics

8 Cancer Profiling Market, By Technology (Page No. – 63)
8.1 Introduction
8.2 Next-Generation Sequencing (NGS)
8.3 Quantitative Polymerase Chain Reaction (QPCR)
8.4 Immunohistochemistry (ICH)
8.5 in Situ Hybridization (ISH)
8.5.1 Fluorescence in Situ Hybridization (FISH)
8.5.2 Chromogenic in Situ Hybridization (CISH)
8.6 Microarray

9 Cancer Profiling Market, By Region (Page No. – 73)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia-Pacific (APAC)
9.4.1 China
9.4.2 Japan
9.4.3 Rest of Asia-Pacific
9.5 Rest of the World (RoW)

10 Competitive Landscape (Page No. – 95)
10.1 Overview
10.2 Battle for Market Share: Product Launch Was the Key Growth Strategy Adopted By Market Players Between 2013 and 2016
10.3 Product Launches
10.4 Agreements, Collaborations, and Partnerships
10.5 Acquisitions
10.6 Others Strategies

11 Company Profiles (Page No. – 100)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Illumina, Inc.
11.3 Qiagen N.V.
11.4 Neogenomics Laboratories, Inc.
11.5 HTG Molecular Diagnostics, Inc.
11.6 Genomic Health Inc.
11.7 Caris Life Sciences
11.8 Helomics Corporation
11.9 Nanostring Technologies, Inc.
11.10 Oxford Gene Technology
11.11 Ribomed Biotechnologies, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 143)
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Other Developments
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports
12.8 Author Details


【レポート販売概要】

■ タイトル:癌・腫瘍プロファイリングの世界市場予測(~2021):用途別、手法別(ゲノミクス、 プロテオミクス、メタボロミクス、エピジェネティックス)、技術別(次世代シーケンシング、qPCR、in-situハイブリダイゼーション、マイクロアレイ)
■ 英文:Cancer/Tumor Profiling Market by Application (Diagnostic, Personalized Medicine, Research), Technique (Genomics, Proteomics, Metabolomics, Epigenetics),Technology (Next-generation Sequencing, qPCR, In-situ Hybridization, Microarray)- Forecast to 2021
■ 発行日:2016年12月6日
■ 調査会社:MarketsandMarkets
■ 商品コード:MD-4803
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。